Diabetes Mellitus: all 11,089 studies
Page 103 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Blood Glucose Response to Meals of Varying Glycemic Index in Youth With Type 1 & 2 DiabetesCompletedNCT00545727Not applicable
- Comparison of Enteral Products for Tube Fed Patients With Type 2 DiabetesCompletedNCT00544206Phase 2
- Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)TerminatedNCT00543959Phase 2
- MK0767 and Metformin Combination Study (0767-028)TerminatedNCT00543738Phase 3
- An Intervention Program to Control DiabetesCompletedNCT00543621Phase 4
- An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes MellitusCompletedNCT00542724Phase 3
- Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose MonitoringCompletedNCT00542698Phase 1
- An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT00542633Phase 3
- Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir InjectionsCompletedNCT00542399Phase 4
- Prevalence of Nocturnal Hypoglycemia in Children on a Type 1 Diabetes (TID) Insulin Regimen Using a Continuous Glucose Monitoring System (CGMS)CompletedNCT00542334
- Use of Online Personalized Health Record System to Promote Self-Management of DiabetesCompletedNCT00542204Not applicable
- Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science EnrichmentCompletedNCT00542113Not applicable
- Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes MellitusCompletedNCT00541983Phase 1
- Obesity and Diabetes Prevention Through Science EnrichmentCompletedNCT00541879Not applicable
- Pharmacist Assisted Medication Program Enhancing the Regulation of DiabetesCompletedNCT00541606Not applicable
- Needle Length In Obese Insulin-Using Diabetic SubjectsCompletedNCT00541372Phase 4
- PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+LisproCompletedNCT00540709Phase 4
- Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional FormulasCompletedNCT00540488Phase 3
- Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes MellitusStatus unknownNCT00540462Phase 4
- Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes MellitusCompletedNCT00539890Phase 3
- Risk Factors for Diabetes After Stem Cell TransplantationCompletedNCT00539851
- Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics StudyCompletedNCT00539448Phase 4
- Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With DiabetesWithdrawnNCT00539435Phase 3
- Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes MellitusTerminatedNCT00539409Phase 2/3
- A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin GlargineCompletedNCT00539396Phase 2
- 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes MellitusCompletedNCT00537251Phase 3
- Study to Investigate the Pathophysiology of Type 2 Diabetes in YouthCompletedNCT00536250
- Duodenal Exclusion for the Treatment of Type 2 DiabetesWithdrawnNCT00534547Not applicable
- A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy AdultsCompletedNCT00532610Phase 1
- Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes MellitusCompletedNCT00532506Phase 2
- Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes MellitusCompletedNCT00530881Phase 2
- Clinical Assessment of GSK716155 for Type 2 Diabetes MellitusCompletedNCT00530309Phase 1
- Continuous Glucose Monitoring in Patients With Type 2 DiabetesStatus unknownNCT00529815Phase 4
- The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human InsulinCompletedNCT00529165Not applicable
- Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)CompletedNCT00526552
- Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes MellitusCompletedNCT00526513Phase 4
- Proleukin and Rapamune in Type 1 DiabetesCompletedNCT00525889Phase 1
- A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin AloneCompletedNCT00525330Phase 2
- A Study Of BRL49653C For The Treatment Of Type 2 DiabetesCompletedNCT00523913Phase 3
- Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
- Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 DiabetesCompletedNCT00522210Not applicable
- Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTerminatedNCT00521820Phase 3
- Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCompletedNCT00521742Phase 3
- The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedNCT00521690Phase 4
- A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT00521378
- Assessment of an Alternative Model of Follow-up of Children and Adolescents With Type 1 DiabetesCompletedNCT00521105Not applicable
- Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00520065Phase 2
- A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of MetforminCompletedNCT00519480Phase 1
- Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes MellitusCompletedNCT00519142Phase 3
- Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline GlargineCompletedNCT00518427Phase 4
- The Finnish Diabetes Prevention StudyActive, not recruitingNCT00518167Not applicable
- The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])CompletedNCT00518102
- A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00517465Phase 1
- A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 DiabetesCompletedNCT00517283Phase 1
- Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DMCompletedNCT00515801Phase 2/3
- Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin TherapyCompletedNCT00515632Phase 3
- Metabolic Effect of Insulin Aspart and Human Insulin in Different DosesCompletedNCT00513643Phase 1
- Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery DiseaseCompletedNCT00513630Phase 4
- Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes MellitusCompletedNCT00513214Phase 1/2
- Lyspro Insulin vs Regular Insulin in Cirrhotic PatientsCompletedNCT00513201Phase 4
- 18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 DiabetesCompletedNCT00511732Phase 2
- Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 DiabetesCompletedNCT00511719Phase 2
- Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 DiabetesCompletedNCT00511602Phase 2
- Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 DiabetesCompletedNCT00508287Phase 1
- Influence of Pioglitazone for Renal Transplant Function in DiabeticsCompletedNCT00507494Phase 3
- Study of CRx-401 on Glucose Levels in Subjects With Type II DiabetesCompletedNCT00506298Phase 2
- Inpatient Self Monitoring and Administration Study (ISMAS)Status unknownNCT00506272Not applicable
- Culturally Tailored Behavioral Diabetes Care Intervention for Korean AmericansCompletedNCT00505960Phase 1
- Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 DiabetesWithdrawnNCT00505882Phase 4
- A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female VolunteersCompletedNCT00504816Phase 1
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedNCT00504673Phase 3
- Preventing Microalbuminuria in Type 2 DiabetesCompletedNCT00503152Phase 3
- A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.CompletedNCT00502710Phase 2
- A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy VolunteersCompletedNCT00501930Phase 1
- 2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented IridesCompletedNCT00501878Phase 4
- Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes MellitusCompletedNCT00501709Phase 1/2
- A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male VolunteersCompletedNCT00501683Phase 1
- Effect of Adiponectin Genetic Polymorphism on Rosiglitazone ResponseCompletedNCT00501488
- A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney FunctionCompletedNCT00501462Phase 1
- A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy VolunteersCompletedNCT00501397Phase 1
- Safety and Efficacy of RT-CGMS in Patients With Type 1 Diabetes Mellitus Treated With an Implantable PumpCompletedNCT00501072Not applicable
- Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of MetforminCompletedNCT00501020Phase 4
- Rosiglitazone on Microalbuminuria in Type 2 DiabeticsCompletedNCT00500955Phase 3
- Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedNCT00499707Phase 3
- Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 DiabetesCompletedNCT00499148Phase 2/3
- Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care ProgramStatus unknownNCT00498147
- Pharmacokinetics of IAsp Following CSII in Patients With T1DMCompletedNCT00497536Phase 4
- Spanish Diabetes Self-Management ProgramCompletedNCT00496145Not applicable
- Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartCompletedNCT00494988Phase 4
- Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT00494884Phase 3
- Preventing ESRD in Overt Nephropathy of Type 2 DiabetesCompletedNCT00494715Phase 3
- A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 DiabetesTerminatedNCT00494663Phase 2
- Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCompletedNCT00494312Phase 4
- Effect of the Fat Content of the Bedtime Snack on Overnight HypoglycemiaCompletedNCT00493935
- Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsCompletedNCT00491725Phase 4
- Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery DiseaseCompletedNCT00491543Phase 2
- The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.Status unknownNCT00491465Not applicable
- Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 DiabetesCompletedNCT00490867Phase 2
- A Study for Patients With Type 2 Diabetes MellitusCompletedNCT00490854Phase 2/3
- Community Based Multiple Risk Factors Intervention StrategyCompletedNCT00490672Phase 4